SUZ12 and malignant peripheral nerve sheath tumor: The increased risk of MPNST in patients with NF1 microdeletion may be related to hemizygosity of the suppressor of zeste 12 homolog (SUZ12) gene, which is located in the NF1 microdeletion region.